Development of drug delivery system for bone formation using cytokine containing DNA film

使用含有细胞因子的 DNA 膜开发骨形成药物输送系统

基本信息

  • 批准号:
    15592091
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2005
  • 项目状态:
    已结题

项目摘要

The self-standing, water-insoluble DNA/lipid films containing cytokine were prepared to develop the Drug Delivery System (DDS) for bone formation. The results were as follows : The DNA/lipid films formed intercalation complexes with ethidium bromide. That indicated that the DNA/lipid films maintained a double helical structure. The tensile strength of DNA/lipid films were 0.8-2.4 MPa and were comparable with a commercial available Membrane for guided tissue regeneration in dental use. There were no inflammatory reactions or inhibition of new tissue formation. And also, the DNA/lipid films showed antibacterial and antifungal activities against bacteria or candida species. On the other hand, the DNA/lipid films were almost dissolved three days after implantation in the backs of rats regardless of lipids structure. Since the chitosan can bind easily to DNA, we chose the chitosan as a reagent combined with DNA instead of artificial lipids. The DNA/chitosan complexes were not toxic to MG-63 osteoblast-like cells and caused only a mild tissue response in the backs of rats. And also, the daunorubicin hydrochloride complex intercalated with DNA/chitosan complexes. On the other hand, the DNA/lipid/poly-lactic-acid films were also investigated. These films also maintained a double helical structure because the daunorubicin hydrochloride complex intercalated with DNA/lipid/poly-lactic-acid films. These results suggest the DNA/chitosan complexes or DNA/lipid/poly-lactic-acid films may be useful as DDS materials
制备了自支撑的、水不溶性的含细胞因子的DNA/脂质膜,以开发用于骨形成的药物递送系统(DDS)。结果表明:DNA/脂质膜与溴化乙锭形成嵌入复合物。这表明DNA/脂质膜保持了双螺旋结构。DNA/脂质膜的拉伸强度为0.8-2.4 MPa,与牙科用引导组织再生的市售膜相当。没有炎症反应或抑制新组织形成。此外,DNA/脂质膜显示出对细菌或念珠菌的抗菌和抗真菌活性。另一方面,无论脂质结构如何,植入大鼠背部后3天,DNA/脂质膜几乎溶解。由于壳聚糖能与DNA结合,因此我们选择壳聚糖代替人工脂质作为与DNA结合的试剂。DNA/壳聚糖复合物对MG-63成骨细胞样细胞没有毒性,仅在大鼠背部引起轻微的组织反应。此外,盐酸柔红霉素复合物插入DNA/壳聚糖复合物。另一方面,还研究了DNA/脂质/聚乳酸膜。这些膜也保持了双螺旋结构,因为盐酸柔红霉素复合物插入DNA/脂质/聚乳酸膜。这些结果表明,DNA/壳聚糖复合物或DNA/脂质/聚乳酸膜可用作DDS材料

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
PBS Buffer Solutions with Different pH Values Can Change Porosity of DNA-chitosan Complexes
不同pH值的PBS缓冲溶液可以改变DNA-壳聚糖复合物的孔隙率
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T.Fukushima;T.Hayakawa;M.Kawaguchi;R.Ogura;Y.Inoue;K.Morishita;K.Miyazaki
  • 通讯作者:
    K.Miyazaki
抗菌性を有する床用レジンの試作
具有抗菌性能的地板树脂原型
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    上西秀則;小倉理恵子;豊田美香;長環;井上勇介
  • 通讯作者:
    井上勇介
Intercalation behavior and tensile strength of DNA-lipid films for the dental application
  • DOI:
    10.1016/j.biomaterials.2004.01.006
  • 发表时间:
    2004-11-01
  • 期刊:
  • 影响因子:
    14
  • 作者:
    Fukushima, T;Hayakawa, T;Okahata, Y
  • 通讯作者:
    Okahata, Y
Antifungal activity of DNA-lipid complexes and DNA-lipid films against candida species
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

INOUE Yusuke其他文献

Real-Time Frame-Rate Control for Energy-Efficient On-Line Object Tracking
用于节能在线对象跟踪的实时帧速率控制

INOUE Yusuke的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('INOUE Yusuke', 18)}}的其他基金

Circulation physiology of continuous flow with artificial heart
人工心脏连续流动的循环生理学
  • 批准号:
    25670105
  • 财政年份:
    2013
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Legal and ethical issues in using stored human biological samples for cancer science
使用储存的人类生物样本进行癌症科学的法律和伦理问题
  • 批准号:
    24701040
  • 财政年份:
    2012
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of micro circulation camera device for analysis of total artificial heart driving pattern
开发用于分析全人工心脏驱动模式的微循环摄像装置
  • 批准号:
    23800020
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Study of the nuclear receptors involved in fatty livers; establishment of a new pathological model and development of therapeutic application.
脂肪肝相关核受体的研究;
  • 批准号:
    22590354
  • 财政年份:
    2010
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Empirical analysis on bioethics policy making
生命伦理政策制定的实证分析
  • 批准号:
    21790493
  • 财政年份:
    2009
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of DNA/chitosan/lipid complex multi-layer membrane for GTR, GBR
GTR、GBR用DNA/壳聚糖/脂质复合物多层膜的开发
  • 批准号:
    19592277
  • 财政年份:
    2007
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An integrated imaging approach to tumor model animals using bioluminescence imaging and magnetic resonance imaging
使用生物发光成像和磁共振成像对肿瘤模型动物进行综合成像方法
  • 批准号:
    18390329
  • 财政年份:
    2006
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study of cytokine-carrier material by using polymer-film made from artificial lipid coated polysaccharide
人工脂质包覆多糖聚合物膜细胞因子载体材料的研究
  • 批准号:
    12671917
  • 财政年份:
    2000
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of light-cured bonding a gent which bond to polished dentin
开发出可与抛光牙本质粘合的光固化粘合剂
  • 批准号:
    09672030
  • 财政年份:
    1997
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Construction of bonding system by using total self-etching primer
全自蚀底漆粘合体系构建
  • 批准号:
    06671983
  • 财政年份:
    1994
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Development of platform for non-invasive, rapid, and simple analysis of cytokine secretion from single cells
开发非侵入、快速、简单分析单细胞细胞因子分泌的平台
  • 批准号:
    23H01824
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Therapeutic approach to confer an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine in effector T cells
赋予效应T细胞中促肿瘤细胞因子IL-6抗肿瘤作用的治疗方法
  • 批准号:
    23K06723
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Diversity of haematopoietic cytokine receptor activation exploring with marine probes
用海洋探针探索造血细胞因子受体激活的多样性
  • 批准号:
    23K14019
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A point-of-care salivary cytokine test for early detection of oral cancer
用于早期发现口腔癌的即时唾液细胞因子检测
  • 批准号:
    10760626
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Development of Coccidioides Cytokine Release Assay
球孢子菌细胞因子释放测定的发展
  • 批准号:
    10760131
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
  • 批准号:
    10681898
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Cytokine Regulation of Secondary Neural Progenitors
次级神经祖细胞的细胞因子调节
  • 批准号:
    10752901
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Generating a novel conditional knockout mouse for a super-enhancer that controls cytokine responsiveness
生成一种新型条件敲除小鼠,用于控制细胞因子反应的超级增强子
  • 批准号:
    10740932
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
Cytokine receptor common beta chain alterations in mediastinal lymphomas
纵隔淋巴瘤细胞因子受体常见β链改变
  • 批准号:
    489197
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了